(PharmaNewsWire.Com, December 18, 2017 ) According to the report Head and Neck Cancer Diagnostics, published by Market Data Forecast, the Europe market is projected to reach USD 3.35 billion by 2021, at a CAGR of 10.85% from 2016 to 2021.
While Head and Neck cancer is rated as being among the top ten most widespread types of cancers in the world, it is highly prevalent in those regions where the consumption of tobacco and alcohol is high. For the proper cure of cancer, there is a requirement for early diagnosis of cancer with prompt treatment. With rising awareness among individuals, there is an growth in number of diagnostic procedures for head and neck cancer, particularly oral and pharyngeal cancers, inducing growth in the market.
Europe Head and Neck Cancer Diagnostics: Drivers & Restraints
The key reason for the growth of the market is attributed rising demand for diagnostic imaging, new advancements and innovations in treatment modes, and incorporation of novel technologies in diagnostic equipment. The head and neck cancer diagnostics market is expected to grow in the future with an increasing number of incidence of the disease.
Factors like rising demand for diagnostic imaging, new advancements and innovations in treatment modes are affecting the growth of this market positively. The market is expected to have a high growth rate in the forecast period owing to rising consumption of tobacco and alcohol in the region.
Europe Head and Neck Cancer Diagnostics: Region-wise Outlook
On the basis of geography, the market is segmented under various regions in Europe namely, France, U.K Germany, Spain and Italy. The increase in the demand for diagnostic imaging market, advancements in modes of treatment, and incorporation of new innovations and novel technologies in diagnostic equipment is believed to further propel the growth of the market during the forecast period.
Key Questions Answered
What is the current and future Head and Neck Cancer Diagnostics outlook in Europe market? What trends are affecting the Europe market?
What is the competitive landscape and market share of major players in the Head and Neck Cancer Diagnostics space in Europe market?
What are the key, high growth markets that Head and Neck Cancer Diagnostics manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Head and Neck Cancer Diagnostics currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Head and Neck Cancer Diagnostics?
What are the challenges and barriers that have hindered widespread adoption of Head and Neck Cancer Diagnostics?
Europe Head and Neck Cancer Diagnostics: Key Players
Some of the major companies dominating Europe Head and Neck Cancer Diagnostics Market are Philips Healthcare, GE Healthcare, Varian Siemens Healthcare, Medical Systems, Shimadzu Corporation, Velscope VX, Identafi, AdDent Inc.
Reasons to buy Europe Head and Neck Cancer Diagnostics Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Healthcare and Pharmaceuticals Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
